Selenium intake, status, and health: a complex relationship.

Rayman MP. · 2020

Read Selenium intake, status, and health: a complex relationship. by Rayman MP. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7033057.txt.

Introduction

Rayman reviews selenium and health in the journal Hormones, writing as sole author. Selenium is a trace element that the body needs only in small amounts. Both shortage and excess occur naturally in different parts of the world, and excess can also come from supplements. Health effects often follow a U-shaped pattern, with harm at both low and high status.

Why people differ in tolerance takes up much of the review. Gene variants can help some handle very low or high intakes. Exposure to toxic elements that bind selenium can blunt its harm. Dose and chemical form matter too: at high doses one form, selenomethionine, produces toxic breakdown products. Early-life exposure may even reshape gut microbes so that excess selenium leaves the body faster. The picture is a balance, not a simple more-is-better rule.

Catalog record

CREATORRayman MP.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7033057

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Selenium intake, status, and health: a complex relationship By Margaret P Rayman Published in: Hormones (Athens, Greece) DOI: 10.1007/s42000-019-00125-5 ABSTRACT Both selenium (Se) deficiency and excess are found in natural locations throughout the world, though Se excess can also be caused by supplementation with Se. Both have been associated with adverse health effects that have often been characterized by a U-shaped relationship. Some health effects, such as increased mortality, are associated with both low and high Se status. Certain people and populations are better able to tolerate low or high Se intake than others; there are a number of possible explanations for this fact. Firstly, it may relate to the presence of polymorphisms (SNPs) in genes that improve the ability to deal with a low or high Se intake. Secondly, high Se status, with apparent absence of toxicity and even beneficial effects, can be found in populations exposed to toxic elements that are known to interact with Se, forming complexes in some cases. Thirdly, beneficial and harmful effects of Se depend on Se dose and form (speciation); for instance, at a high dose, selenomethionine (SeMet) has toxic effects that are mediated by metabolism to selenols/selenolates that can redox-cycle, generate superoxide radicals and react with thiols/diselenides to produce selenyl sulphides/disulphides. Finally, it is possible that exposure to a high Se intake from birth or from a very young age may alter the composition of the gut microbiota in such a way that excess Se is more readily excreted, thus reducing its toxicity. INTRODUCTION The highly insightful observation made by Confucius (551 to 479 BC), “Excess and deficiency are equally at fault”, is as relevant today as it was 2500 years ago, and it applies to almost all nutrients, though it is particularly apposite to selenium (Se). Se intake is extremely variable across the world [1] owing to a number of factors, including the Se content of the soil in which crops and fodder are grown, Se speciation, soil pH and organic-matter content, and the presence of ions that can complex with Se [2]. This fact enables the effects of both Se deficiency and excess to be observed in the natural world. EFFECTS OF SE DEFICIENCY Some adverse health conditions associated with Se deficiency are listed in Table 1.Table 1Conditions that have been associated with Se deficiency [3]ConditionReferenceKeshan disease[2]Kashin-Beck disease[4]Increased viral virulence[5]Increased mortality[6]Poorer immune function[7]Problematic fertility/reproduction[3]Thyroid autoimmune disease[8]Cognitive decline/dementia[9–11]Type 2 diabetes[12]Prostate cancer risk[13]Colorectal cancer risk in women (seen in EPIC)[14] A further example that is less well known relates to the reduction in risk of incident tuberculosis (TB) in HIV-infected subjects who were treated with Se. Because HIV is an immune-deficiency syndrome, those with this disease commonly suffer from other infections, such as TB, particularly as the condition progresses [15]. In a 24-month, four-arm, randomized, controlled trial (RCT) in 878 HIV-infected adults in Botswana, who were randomized to Se, multivitamins, Se+multivitamins or placebo, treatment with 200 μg Se+multivitamins significantly reduced the risk of immune decline and morbidity, while multivitamins alone and Se alone had no effect [16]. Importantly, Se vs. placebo significantly reduced the risk of incident TB: hazard ratio (HR) 0.20, 95%; confidence interval (CI): 0.04, 0.95; P = 0.043. When the Se and Se+multivitamin arms were combined, the risk of TB was also reduced: HR 0.32, 95% CI: 0.11, 0.93; P = 0.036 [15]. This is an important finding in relation to HIV outcome, particularly in sub-Saharan Africa, where TB can often be fatal. EFFECTS OF SE EXCESS The effects of Se excess are probably less well known. Apart from some occasional cases of overdose where people have ingested wrongly formulated supplements [17], Se excess has mostly been observed in RCTs, where doses of 200 μg/day or more of Se have been given for a substantial period of time (see Table 2).Table 2Health risks significantly related to selenium excessHealth conditionReferenceSelenosis (Se toxicity)[2, 17]Alopecia (seen in SELECT)[18]Dermatitis (seen in SELECT)[18]Non-melanoma skin cancer (seen in NPC trial)[19]Increased mortality[6] [20]Type 2 diabetes (seen in the NPC trial)[21]Increased prostate cancer risk (seen in SELECT)[22] ADVERSE HEALTH EFFECTS ASSOCIATED WITH, OR CAUSED BY, BOTH SE DEFICIENCY AND EXCESS: SE AND MORTALITY It is of note that some health conditions are associated with both Se deficiency and excess, i.e. increased mortality, type 2 diabetes and increased prostate cancer risk [6, 12, 13]. Increased mortality is seen at both low and high plasma Se concentrations. This was first demonstrated by the Guallar group at Johns Hopkins School of Public Health, Baltimore, USA, which examined data from the US Third National Health and Nutrition Examination Survey. Serum Se was measured in 13,887 adult participants who were then followed up for mortality for up to 12 years [6] and subsequently for a further 6 years [3]. Mortality showed a U-shaped association, reaching a minimum at a serum Se concentration of 135 μg/L. Increased mortality was seen at the highest dose level of an RCT of Se in the Danish PRECISE trial, a randomized, double-blinded, placebo-controlled, clinical trial with four groups [20]. Participants were 491 male and female volunteers aged 60–74 years who were randomly assigned to treatment with 100, 200 or 300 μg Se/day as Se-enriched yeast or placebo yeast for 5 years from randomization in 1998–1999 and were followed up for mortality for a further 10 years. In an intention-to-treat analysis, the HR (95% CI) for all-cause mortality comparing 300 μg Se/day with placebo was 1.62 (0.66, 3.96) after 5 years of treatment and 1.59 (1.02, 2.46) over the entire follow-up period [20]. The relationship between cumulative mortality from all causes over time by treatment group in the Danish PRECISE RCT is shown in Fig. 1. The results of this study warn that a 300-μg/day dose of Se (as Se yeast) taken for 5 years in a country with moderately low Se status can increase all-cause mortality 10 years later.Fig. 1Cumulative mortality from all causes over time by treatment group. Non-parametric cumulative mortality curves (step functions) were estimated via the Kaplan-Meier method and compared with results generated by the generalized Wilcoxon test. Parametric cumulative mortality curves (smooth lines) were estimated from spline-based parametric survival models with treatment-specific log cumulative hazards parameterized as natural cubic splines of log time with knots at the 33th and 67th percentiles of the uncensored log-time distribution. Cumulative mortality estimates (95% CIs) at 5, 10 and 15 years of follow-up by treatment group were obtained from spline-based parametric survival models. Se denotes selenium [20] (published with permission of FRBM) The relationship between Se intake/status and mortality is an excellent example of the U-shaped association between Se and health. Figure 2 illustrates that relationship, additionally including data referred to in Tables 1 and 2 [23].Fig. 2U-shaped relationship between Se status and disease risk (for references, see [3]) COMPLEXITIES IN THE RELATIONSHIP BETWEEN SE INTAKE AND HEALTH EFFECTS: FACTORS THAT NEED TO BE CONSIDERED Though the results of the Danish PRECISE trial show excess mortality on long-term (5 year) exposure to 300 μg Se/day as Se yeast of a population experiencing much lower Se exposure (plasma-Se concentration at baseline, 89 μg/L, that rose to 284 μg/L after 5 years) [20], it is notable that population groups with long-term high-Se exposure appear to cope with a Se

Read the complete text